Award recordCONTRACT

ACTELION PHARMACEUTICALS US, INC.

PIID 36C26022F0386· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $142,250 net obligations· UEI H5BMHLMMNA28· CA

Description

UPTRAVI 16MCG NDC 66215-0616-06

First action · last action
2022-07-12 · 2024-07-25
Transactions
3
First transaction's obligation
$167,823
Base + all options value (sum of deltas)
$142,250
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0142
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$171,419$0Base award · 2022-07-12 · this action $167,823 · running total $167,823Modification P00001 · 2023-06-05 · this action $3,595 · running total $171,419Modification P00002 · 2024-07-25 · this action -$29,169 · running total $142,250
  • Base2022-07-12+$167,823= $167,823
  • Mod P000012023-06-05+$3,595= $171,419
  • Mod P000022024-07-25-$29,169= $142,250
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-07-12+$167,823$167,823UPTRAVI 16MCG NDC 66215-0616-06
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-06-05+$3,595$171,419UPTRAVI 16MCG NDC 66215-0616-06
Mod P00002· OTHER ADMINISTRATIVE ACTION2024-07-25−$29,169$142,250UPTRAVI 16MCG NDC 66215-0616-06

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H5BMHLMMNA28)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0477245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$47,052FY2026
36C24526N0181245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$22,235FY2026
36C26026F0024260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$65,500FY2026
36C26026F0017260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$406,538FY2026
36C26025F0209260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$197,168FY2025
36C26025F0107260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$70,630FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26022F0386_3600_36F79719D0142_3600 · retrieved 2026-09-26.